TEI 3313

structure given in first source; a prostaglandin A1 derivative

Also Known As:

5-(4,7-dihydroxy-2-heptenyridene)-4-hydroxy-2-methylthio-4-(4-phenoxybutyl)-2-cyclopentenone; TEI-3313; 2-Cyclopenten-1-one, 5-(4,7-dihydroxy-2-heptenylidene)-4-hydroxy-2-(methylthio)-4-(4-phenoxybutyl)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins A: 1719
        TEI 3313: 1
Biological Factors: 2472
- Inflammation Mediators: 1113
  - Autacoids: 276
    - Eicosanoids: 3262
      - Prostaglandins: 17100
        Prostaglandins A: 1719
        TEI 3313: 1

Related Diseases

1.	Body Weight (Weight, Body) 10/01/1995 - "The administration of up to 500 micrograms/kg of TEI-3313 to rats had no effect on body weight or on serum calcium, inorganic phosphorus and 1 alpha,25 dihydroxy vitamin D3 levels. "

Related Drugs and Biologics

1.	Phosphorus (Red Phosphorus)
2.	Calcium
3.	dihydroxy-vitamin D3